← Leaderboards
Jean-Baptiste O Roullet
Oregon Health And Science University
$2,102,469
Attributed
$2,424,366
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $602.5K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,487,268 · 10
By mechanism
U54$1,722,907 · 2
R01$602,492 · 1
R41$453,535 · 3
R15$346,334 · 1
R21$302,000 · 1
R13$60,000 · 2
Top collaborators
- Robert David Steiner2 shared
- K Michael Gibson1 shared
- Alice Mcconnell1 shared
- Javier Ochoa-Reparaz1 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- K Michael Gibson$9,768,649
- Robert David Steiner$9,602,991
- William E Connor$1,861,965
- John K Belknap$5,892,853
- John C. Crabbe$13,413,013
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainClinical ResearchNatural HistoryMutationFamilyResearch PersonnelFutureMetabolismBiological MarkersBiochemicalChildTreatment EfficacyGenesAffectIsoprenoidDisease Natural HistoryOxidoreductaseParticipantPathogenesisCholesterolLearningEvaluationMagnetic Resonance ImagingEnzymes
Grant awards (16)
Natural History of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD), a Heritable Disorder of GABA Metabolism$602,492
R01 · FY2022 · HD · contact PI
2020 International Scientific conference on succinic semialdehyde dehydrogenase deficiency (SSADHD)$20,000
R13 · FY2020 · NS · contact PI
Targeting the GABA-modulator microbiota against the progression of CNS inflammatory demyelination$346,334
R15 · FY2019 · NS
Farnesol as Novel Treatment in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$223,095
R41 · FY2018 · NS
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients$120,001
U54 · FY2018 · HD · contact PI
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients$120,001
U54 · FY2017 · HD · contact PI
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients$120,001
U54 · FY2016 · HD · contact PI
2016 International Conference on Plant Sterols, Health & Diseases$40,000
R13 · FY2016 · AT · contact PI
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients$120,001
U54 · FY2015 · HD · contact PI
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients$180,001
U54 · FY2014 · HD · contact PI
Sterol and Isoprenoid Diseases Consortium$517,545
U54 · FY2013 · HD · contact PI
Sterol and Isoprenoid Diseases Consortium$545,357
U54 · FY2012 · HD · contact PI
Retinoids as Novel Treatment of Ischemic Stroke$130,453
R41 · FY2006 · NS · contact PI
Farnesol Analogues as Novel Treatment of Alcoholism$99,987
R41 · FY2005 · AA
Ethanol &Farnesol: Metabolic Interactions$151,000
R21 · FY2003 · AA
Ethanol &Farnesol: Metabolic Interactions$151,000
R21 · FY2002 · AA